PolyPid completes FDA submission for surgical infection prevention drug Jun 1, 2026 08:32AM
PolyPid Ltd. (PYPD) Tops Q1 EPS by 70c May 13, 2026 07:30AM
PolyPid begins FDA submission for surgical infection drug Mar 31, 2026 08:30AM
PolyPid Ltd. (PYPD) Misses Q4 EPS by 8c Feb 11, 2026 07:41AM
PolyPid advances D-PLEX100 partnership talks, plans NDA filing Feb 11, 2026 07:31AM


Dec 3, 2025 08:32AM PolyPid receives FDA support for D-PLEX100 drug application submission
Dec 1, 2025 04:36AM PolyPid's (PYPD) DPLEX100 Demonstrates Positive Phase 3 Results - Citizens
Nov 12, 2025 08:04AM PolyPid Ltd. (PYPD) Misses Q3 EPS by 4c
Sep 16, 2025 08:33AM PolyPid completes israeli health ministry GMP inspection
Aug 13, 2025 08:23AM PolyPid Ltd. (PYPD) Misses Q2 EPS by 21c
Jul 15, 2025 08:00AM PolyPid unveils 60-day GLP-1 delivery platform for diabetes treatment
Jun 17, 2025 04:08AM PolyPid Ltd. (PYPD) PT Lowered to $14 at Citizens JMP
Jun 10, 2025 06:38AM PolyPid Ltd. (PYPD) PT Raised to $13 at H.C. Wainwright
Jun 9, 2025 10:13AM PolyPid (PYPD) shares surge on successful D-PLEX100 trial results
Jun 9, 2025 07:32AM PolyPid Ltd. (PYPD) to Host Conference Call and Webcast to Discuss D-PLEX₁₀₀ SHIELD II Phase 3 Trial Topline Results on Monday, June 9, 2025
Jun 2, 2025 06:38AM H.C. Wainwright Assumes PolyPid Ltd. (PYPD) at Buy
May 14, 2025 04:45PM PolyPid Ltd. (PYPD) Tops Q1 EPS by 22c
Apr 14, 2025 06:54AM H.C. Wainwright Reiterates Buy Rating on PolyPid Ltd. (PYPD)
Feb 3, 2025 04:43AM JMP Securities Biotechnology Overview
Jan 28, 2025 06:44AM Rodman & Renshaw Starts PolyPid Ltd. (PYPD) at Buy
Dec 26, 2024 06:35AM PolyPid Ltd. (PYPD) PT Lowered to $11 at H.C. Wainwright
Dec 11, 2024 07:02AM PolyPid Ltd. (PYPD) Announces Research and Development Collaboration with ImmunoGenesis Leveraging PLEX Technology to Enhance Cancer Immunotherapy
Nov 29, 2024 01:06PM PolyPid Ltd. (PYPD) Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance
Nov 4, 2024 09:12AM Craig-Hallum Starts PolyPid Ltd. (PYPD) at Buy
Oct 21, 2024 07:02AM PolyPid Ltd. (PYPD) Announces Publication in International Journal of Surgery Highlighting Results of Phase 3 SHIELD I Trial of D-PLEX₁₀₀ in Prevention of Surgical Site Infections in Abdominal C
Oct 2, 2024 06:47AM H.C. Wainwright Reiterates Buy Rating on PolyPid Ltd. (PYPD)
Oct 1, 2024 07:04AM PolyPid (PYPD) Announces Last Patient In for Planned Unblinded Interim Analysis in the Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX100 for the Prevention of Abdominal Colorectal Surgical Site Inf
Aug 30, 2024 04:05PM PolyPid Ltd. (PYPD) Files for 3.91M Share Offering by Selling Stockholders
Aug 14, 2024 07:15AM PolyPid Ltd. (PYPD) Tops Q2 EPS by 5c